Insiders · Profile

Buck Jill

EVP, GM Gene Therapy at Alaunos Therapeutics. Filing since 2 Jan 2020. CIK 0001780426

Company
Date
Role
Action
Shares
Amount
Of holding
8 Jan 2021
EVP, GM Gene Therapy
Sold, plan not stated
27,894
$87.03K
12.3%
2 Jan 2020
EVP, GM Gene Therapy
Sold, plan not stated
27,923
$127.05K
13.8%
2 decisions on file.